Abbott Laboratories

Traded on the St. Petersburg Stock Exchange
Abbott Laboratories is an American chemical-pharmaceutical corporation. It was founded in 1888 by Dr. Wallace Abbott in Chicago under the name Alkaloidal Abbott Laboratories' Company, and got its modern name in 1915. Its headquarters are located in Abbott Park, Illinois, USA.
Abbott Laboratories stock price chart
+13%
P/E adj.
Net profit (adj.)
P/B
Book value
Debts
Net debt
Yield
Growth potential

Abbott Laboratories balance sheet

Report period2018 2019 2020 2021 2022 Q2 23
End date of the reporting period
Capitalization, $
Capitalization, $
Enterprise Value
Book Value
Shareholders Book Value
Current liabilities
Noncurrent liabilities
Total liabilities
Debt
Cash and cash equivalents
Net debt
Assets
Total ordinary shares
Ordinary share price

Abbott Laboratories cash flows

Report period2018 2019 2020 2021 2022 Q2 23 TTM
End date of the reporting period
Sales
Gross profit
Operation Income
Earnings
Shareholders earnings
Adjusted Earnings
EBITDA
Operation Cashflow
Capital expenditure
Free Cash Flow
EPS
Adjusted EPS

Abbott Laboratories multipliers

Report period2018 2019 2020 2021 2022 Q2 23 TTM
P/E
P/E adj.
E/P
E adj./P
P/B
P/S
P/FCF
L/A
Debt-To-Equity
Net Debt/EBITDA
EV/EBITDA

Abbott Laboratories profitability

Report period2018 2019 2020 2021 2022 Q2 23 TTM
ROA
ROE
ROS
Gross margin
EBITDA Margin
Operating margin
Abbott Laboratories assets
Abbott Laboratories cash flows
Abbott Laboratories dividends
2.49%

Abbott Laboratories shares

TickerNameTypeNominal valueISINPrice
ABT:USAbbott LaboratoriesCommon share-US0028241000$118.6
Abbott Laboratories news
18.10.2023
Abbott Laboratories' GAAP net income for 9 months of 2023 was $4.129 billion, down 30% from $5.9 billion in the prior year. Revenue declined 11% to $29.868 bln vs. $33.562 bln a year earlier.
20.07.2023
Abbott Laboratories' GAAP net income for 6 months of 2023 was $2.693 billion, down 39.7% from $4.465 billion in the prior year. Revenue declined 14.8% to $19.725 billion from $23.152 billion a year earlier.
28.04.2023
Abbott has completed acquisition of Cardiovascular Systems for $890 million. Company develops solutions for revascularization of patients with complex coronary and peripheral artery disease.
Source: {source} pictogram abbott.com
19.04.2023
Abbott Laboratories' GAAP net income for 3 months of 2023 was $1.318 billion, down 46.1% from $2.447 billion in the previous year. Revenue decreased 18.1% to $9.747 billion from $11.895 billion a year earlier.
General information
Company nameAbbott Laboratories
Tags#medtech, #dividend aristocrats, #s&p500 index
SectorHealth Care / Health Care Equipment & Services / Health Care Equipment & Supplies / Health Care Equipment
Business address100 ABBOTT PARK ROAD ABBOTT PARK IL 60064-3500 2246676100
Mailing address100 ABBOTT PARK ROAD ABBOTT PARK IL 60064-3500
Websitewww.abbottinvestor.com
Information disclosurewww.sec.gov